IMRX
IMRX
NASDAQ · Biotechnology

Immuneering Corp - Class A

Penny Stocks Biotech Stocks Healthcare Stocks
$3.75
-0.28 (-6.84%)
As of Nov 7, 2:13 AM ET ·
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Buy 12 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target -5.5% upside
Low Target $2.50
Average Target $3.54
High Target $3.55
Current Price $3.75
Current
$3.75
Target
$3.54
$2.50 $3.54 avg $3.55
Scenario Analysis
Bear Case
$2.50
-33.2%
Low target
Base Case
$3.54
-5.5%
Avg target
Bull Case
$3.55
+-5.2%
High target
Risk/Reward
0.2x
Unfavorable
Price in Context
52-Week High
$8.48
-55.8% from high
52-Week Low
$3.35
+11.8% from low
Target vs 52W High
$3.54
-58.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -11.6%
AMGN
Amgen Inc
 Hold 42 43% $190.87 -58.5%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +117.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 82% $438.34 -19.9%
MRNA
Moderna Inc
 Hold 31 35% $149.45 -41.2%
REGN
Regeneron Pharmaceuticals
 Buy 37 70% $76.80 -91.5%
NTRA
Natera Inc
 Strong Buy 30 90% $142.91 -54.0%
RVMD
Revolution Medicines Inc
 Strong Buy 29 93% $114.11 -40.7%